Company Filing History:
Years Active: 2012
Title: The Innovations of Patrick Eric Hanrahan
Introduction
Patrick Eric Hanrahan is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds aimed at treating metabolic disorders. His work is characterized by a focus on opioid receptor modulators, which have potential applications in addressing obesity and related health issues.
Latest Patents
Hanrahan holds a patent for "Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders." This patent describes compounds of formula (I) or pharmaceutically acceptable salts thereof, which function as opioid receptor modulators. Specifically, these compounds can act as mu-opioid receptor antagonists, neutral antagonists, or inverse agonists, making them useful in the treatment of metabolic disorders, including obesity. He has 1 patent to his name.
Career Highlights
Throughout his career, Hanrahan has been associated with Prosidion Limited, a company dedicated to advancing therapeutic solutions for metabolic diseases. His work at Prosidion has allowed him to explore innovative approaches to drug development, contributing to the company's mission of improving patient outcomes.
Collaborations
Hanrahan has collaborated with notable colleagues, including Jason Bloxham and Stuart Edward Bradley. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
Patrick Eric Hanrahan's contributions to the field of metabolic disorder treatment through his innovative patent work exemplify the impact of dedicated inventors in advancing healthcare solutions. His ongoing efforts at Prosidion Limited continue to pave the way for future developments in this critical area of medicine.